TrialAnnals of oncology : official journal of the European Society for Medical Oncology2010

Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.

G Viale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.